>Chimeric antigen receptor (CAR) T cells targeting CD19 or CD22 have significant activity in the treatment of B-cell acute lymphoblastic leukemia (B-ALL)
Chinese experts discover new treatment targets for children with medulloblastoma
Time of Update: 2021-09-13
In vivo and in vitro experiments have shown that microRNA molecules derived from exosomes play an important role in the occurrence and development of childhood medulloblastoma, and can become a potential diagnostic and therapeutic target for children with medulloblastoma .
NEJM: Lung cancer targeted drug successfully rescued children with ALK fusion-positive high-grade glioma on the verge of death
Time of Update: 2021-09-04
The paralysis was resolved within one week after resuming treatment, and a follow-up MRI after 1 month showed that the response of all lesions to treatment was nearly complete .
ADC drugs targeting CD22 are effective in children with R/R ALL
Time of Update: 2021-04-19
Recently, Professor Erica Brivio and others reported the results of a phase I clinical study (ITCC-059 trial) on the efficacy and safety of CD22-targeted ADC drug IO in the treatment of CD22+ children with R/R ALL.
Hepatology: Identify new potential gene targets for the treatment of liver cancer in children
Time of Update: 2020-07-09
In a recent study published in the international journal Hepatology, scientists from the University of Massachusetts School of Medicine and others identified potential new therapeutic targets for hepatoblastoma, a rare form of childhood liver cancer
Cancer cell: targeted therapy helps to treat children's fatal nerve cancer
Time of Update: 2019-10-20
Researchers in Mount Sinai have found that the deletion of the ATRX gene in neuroblastoma in older children and adolescents may lead to a response to targeted treatment of tazemetostat.
Nature journal: finding potential therapeutic targets of malignant liver cancer in children
Time of Update: 2018-06-13
June 13, 2018 / Biovalley BIOON / - hepatoblastoma (HBL) is a kind of malignant pediatric liver cancer that occurs before the age of 3 in children
A common phenomenon
Pay attention to differentiation! Children's cough relief methods should be targeted
Time of Update: 2017-06-27
Later, the doctor opened a bottle of Yitanjing and hospital made medicine ( and the disease was relieved after taking them.
FDA approval of vertex cystic fibrosis targeting drug kalydeco for 2-5 years old children
Time of Update: 2015-03-20
Kalydeco's expanded indications were approved on the basis of an open label 24 week phase III clinical trial that investigated the safety and pharmacokinetics of a new formula based on body weight (50mg or 75mg twice daily) in 2-5-year-old children.